During the past decade, Family Prescription Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Family Prescription Center" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator and "McNeil AB" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Family Prescription Center" are "Frequent Heartburn" (1 trials), "Hypercholesterolemia" (1 trials), "Pain" (1 trials), "Patient Compliance" (1 trials) and "Tobacco Dependence" (1 trials). Many other conditions were trialed in "Family Prescription Center" in a lesser frequency.

Most popular intervention types in "Family Prescription Center" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Atorvastatin calcium 10 mg" (1 trials), "Ibuprofen 400 mg caplet" (1 trials), "Ibuprofen 600 mg Immediate Release/Extended Release Caplet" (1 trials), "Nicotine" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Family Prescription Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Family Prescription Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Family Prescription Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Family Prescription Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".